AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-MEDICAL LABORATORIES
Cardiol Therapeutics Inc. Class A Common Shares
XNAS · usd
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG00M0GNQ75
1.12▼ 0.03 (-2.61%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
1.15
Day's Range
1.11 – 1.16
52-Week Range
0.88 – 2.34
Volume
1.1M
Avg Volume
1.3M
Share Statistics
Shares Outstanding
Employees
18
Exchange
XNAS
Listed
2019-01-15
Share count as of December 31, 2025

Cardiol Therapeutics Inc. Class A Common Shares (CRDL) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Cardiol Therapeutics Inc. Class A Common Shares (CRDL)
What is Cardiol Therapeutics Inc. Class A Common Shares's Market Cap?
Cardiol Therapeutics Inc. Class A Common Shares's Market Cap is $112.3M, based on as-reported figures from SEC (XBRL) filings.
What is Cardiol Therapeutics Inc. Class A Common Shares's Enterprise Value?
Cardiol Therapeutics Inc. Class A Common Shares's Enterprise Value is $96.7M, based on as-reported figures from SEC (XBRL) filings.
What is Cardiol Therapeutics Inc. Class A Common Shares's EV / EBITDA?
Cardiol Therapeutics Inc. Class A Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Cardiol Therapeutics Inc. Class A Common Shares's Net Income (TTM)?
Cardiol Therapeutics Inc. Class A Common Shares's Net Income (TTM) is -$24.7M, based on as-reported figures from SEC (XBRL) filings.
What is Cardiol Therapeutics Inc. Class A Common Shares's EBITDA?
Cardiol Therapeutics Inc. Class A Common Shares's EBITDA is -$25.0M, based on as-reported figures from SEC (XBRL) filings.
What is Cardiol Therapeutics Inc. Class A Common Shares's Diluted EPS (TTM)?
Cardiol Therapeutics Inc. Class A Common Shares's Diluted EPS (TTM) is -0.25, based on as-reported figures from SEC (XBRL) filings.
What is Cardiol Therapeutics Inc. Class A Common Shares's Net Debt?
Cardiol Therapeutics Inc. Class A Common Shares's Net Debt is -$15.6M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CRDLAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of CAD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Operating expenses (notes 11, 15, 16)
General and administration (note 15)
Research and development (note 15)
Loss before other income (expenses)
Interest income (note 6)
Gain (loss) on foreign exchange
Change in derivative liability (note 9)
Other income—
Net loss and comprehensive loss for the year